Literature DB >> 17028373

Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Jon F Watchko1.   

Abstract

Kernicterus is a devastating, chronic disabling neurological disorder whose central nervous system (CNS) sequelae reflect both a predilection of bilirubin toxicity for neurons (rather than glial cells) and the regional topography of bilirubin-induced neuronal injury that is characterized by prominent basal ganglia, cochlear, and oculomotor nuclei involvement. The molecular pathogenesis of bilirubin-induced neuronal cell injury, although incompletely understood, likely reflects the untoward effects of hazardous unconjugated bilirubin concentrations on plasma, mitochondrial, and/or endoplasmic reticulum (ER) membranes. These membrane perturbations, in turn, might lead to the genesis of neuronal excitotoxicity, mitochondrial energy failure, or increased intracellular calcium concentration [Ca2+]i. These three phenomena are likely to be linked spatially and temporally in the pathogenesis of bilirubin-induced neuronal injury. Downstream events triggered by increased [Ca2+]i may include, among others, the activation of proteolytic enzymes, apoptotic pathways, and/or necrosis, the individual occurrence of which is likely a function of the degree and duration of bilirubin exposure. A recent study demonstrates the activation of mitogen-activated protein kinase signal transduction pathways by bilirubin heralding a degree of complexity regarding the molecular mechanism(s) of bilirubin-induced neurotoxicity not previously appreciated. There remains, however, a paucity of data regarding specific effects of bilirubin on intracellular signaling and cell death pathways, particularly in vivo. An enhanced understanding of the molecular pathogenesis of bilirubin-induced neuronal injury will lead to the identification of potential novel interventional strategies to protect the CNS against kernicterus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028373     DOI: 10.1385/NMM:8:4:513

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  103 in total

1.  The neurological sequelae of Rh sensitization.

Authors:  P R EVANS; P E POLANI
Journal:  Q J Med       Date:  1950-04

2.  Inhibition of glutamate uptake by unconjugated bilirubin in cultured cortical rat astrocytes: role of concentration and pH.

Authors:  R Silva; L R Mata; S Gulbenkian; M A Brito; C Tiribelli; D Brites
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

3.  Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causes.

Authors:  A H Hoon; E M Reinhardt; R I Kelley; S N Breiter; D H Morton; S B Naidu; M V Johnston
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

4.  Expression of the alpha and beta subunits of Ca2+/calmodulin kinase II in the cerebellum of jaundiced Gunn rats during development: a quantitative light microscopic analysis.

Authors:  J W Conlee; S M Shapiro; S B Churn
Journal:  Acta Neuropathol       Date:  2000-04       Impact factor: 17.088

5.  Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons.

Authors:  S Grojean; V Koziel; P Vert; J L Daval
Journal:  Exp Neurol       Date:  2000-12       Impact factor: 5.330

6.  The in vivo effect of bilirubin on the N-methyl-D-aspartate receptor/ion channel complex in the brains of newborn piglets.

Authors:  D J Hoffman; S A Zanelli; J Kubin; O P Mishra; M Delivoria-Papadopoulos
Journal:  Pediatr Res       Date:  1996-12       Impact factor: 3.756

7.  Apoptosis in murine hepatoma hepa 1c1c7 wild-type, C12, and C4 cells mediated by bilirubin.

Authors:  John M Seubert; Alison J Darmon; Ayman O S El-Kadi; Sudhir J A D'Souza; John R Bend
Journal:  Mol Pharmacol       Date:  2002-08       Impact factor: 4.436

8.  Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice.

Authors:  J F Watchko; M J Daood; T W Hansen
Journal:  Pediatr Res       Date:  1998-11       Impact factor: 3.756

Review 9.  Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology.

Authors:  T Valaes
Journal:  Acta Paediatr Suppl       Date:  1994-03

10.  Kernicterus in otherwise healthy, breast-fed term newborns.

Authors:  M J Maisels; T B Newman
Journal:  Pediatrics       Date:  1995-10       Impact factor: 7.124

View more
  34 in total

1.  Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure.

Authors:  Sarah K Himes; Yanling Huo; George K Siberry; Paige L Williams; Mabel L Rice; Patricia A Sirois; Toni Frederick; Rohan Hazra; Marilyn A Huestis
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

2.  Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal.

Authors:  Carolyn G Scrafford; Luke C Mullany; Joanne Katz; Subarna K Khatry; Steven C LeClerq; Gary L Darmstadt; James M Tielsch
Journal:  Trop Med Int Health       Date:  2013-09-23       Impact factor: 2.622

3.  Bilirubin Encephalopathy in a Domestic Shorthair Cat With Increased Osmotic Fragility and Cholangiohepatitis.

Authors:  E T Contreras; U Giger; J L Malmberg; J M Quimby; P A Schaffer
Journal:  Vet Pathol       Date:  2015-09-09       Impact factor: 2.221

4.  Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study.

Authors:  Ellen C Caniglia; Kunjal Patel; Yanling Huo; Paige L Williams; Suad Kapetanovic; Kenneth C Rich; Patricia A Sirois; Denise L Jacobson; Sonia Hernandez-Diaz; Miguel A Hernán; George R Seage
Journal:  AIDS       Date:  2016-05-15       Impact factor: 4.177

5.  Riluzole is a promising pharmacological inhibitor of bilirubin-induced excitotoxicity in the ventral cochlear nucleus.

Authors:  Guo-Ying Han; Chun-Yan Li; Hai-Bo Shi; Ji-Ping Wang; Kai-Ming Su; Xin-Lu Yin; Shan-Kai Yin
Journal:  CNS Neurosci Ther       Date:  2014-12-12       Impact factor: 5.243

Review 6.  Metalloporphyrins in the management of neonatal hyperbilirubinemia.

Authors:  David K Stevenson; Ronald J Wong
Journal:  Semin Fetal Neonatal Med       Date:  2009-12-16       Impact factor: 3.926

7.  [Role of pyroptosis in bilirubin-induced microglial injury].

Authors:  Hong-Mei Huang; Chun-Mei He; Si-Yu Li; Yan Zhang; Zi-Yu Hua
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

Review 8.  High unbound bilirubin for age: a neurotoxin with major effects on the developing brain.

Authors:  Rowena Cayabyab; Rangasamy Ramanathan
Journal:  Pediatr Res       Date:  2018-12-05       Impact factor: 3.756

9.  Transport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy.

Authors:  Silvia Gazzin; Nathalie Strazielle; Claudio Tiribelli; Jean-François Ghersi-Egea
Journal:  Front Pharmacol       Date:  2012-05-18       Impact factor: 5.810

10.  Functional induction of the cystine-glutamate exchanger system Xc(-) activity in SH-SY5Y cells by unconjugated bilirubin.

Authors:  Pablo J Giraudi; Cristina Bellarosa; Carlos D Coda-Zabetta; Paolo Peruzzo; Claudio Tiribelli
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.